These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17356502)

  • 1. [The evaluation of long-term treatment with antipsychotics].
    Millet B
    Encephale; 2006 Dec; 32 Pt 3():S1072-5. PubMed ID: 17356502
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Kujawa et al. letter-to-the-editor.
    Sethuraman G; Taylor CC; Enerson M; Dunayevich E
    Schizophr Res; 2006 May; 84(1):172-3. PubMed ID: 16563702
    [No Abstract]   [Full Text] [Related]  

  • 3. Utilization of long-acting antipsychotic medication in patient care.
    Kane JM
    CNS Spectr; 2006 Dec; 11(12 Suppl 14):1-7; quiz 7-8. PubMed ID: 17146411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacotherapy and remission of patients with schizophrenia.
    Degmecić D; Pozgain I; Filaković P; Dodig-Curković K; Mihanović M
    Coll Antropol; 2009 Jun; 33(2):547-51. PubMed ID: 19662777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
    Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
    Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia: a 4-year follow-up naturalistic study.
    Altamura AC; Buoli M; Mauri MC
    J Clin Psychopharmacol; 2011 Oct; 31(5):661-3. PubMed ID: 21881452
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
    Hayden F
    J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive functions and remission].
    Sarfati Y
    Encephale; 2005 Dec; 31 Pt 2():S21-3. PubMed ID: 16462631
    [No Abstract]   [Full Text] [Related]  

  • 9. [Remission and relapse in the outpatient treatment of patients with schizophrenia. Outcomes at 3 years].
    Haro JM; Ciudad A; Alonso J; Bousoño M; Suárez D; Novick D; Gilaberte I
    Actas Esp Psiquiatr; 2008; 36(4):187-96. PubMed ID: 18461495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Criteria of remission in schizophrenia].
    Gorwood P
    Encephale; 2005 Dec; 31 Pt 2():S18-20. PubMed ID: 16462630
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966.
    Moilanen JM; Haapea M; Jääskeläinen E; Veijola JM; Isohanni MK; Koponen HJ; Miettunen J
    Eur Psychiatry; 2016 Aug; 36():7-14. PubMed ID: 27311102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of Seroquel in schizophrenia].
    Chakhava VO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):63-4. PubMed ID: 11026140
    [No Abstract]   [Full Text] [Related]  

  • 13. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.
    Harrow M; Jobe TH; Faull RN
    Psychol Med; 2012 Oct; 42(10):2145-55. PubMed ID: 22340278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of antipsychotics and their use in the treatment of schizophrenia. What's up, doc?].
    Jufe GS
    Vertex; 2011; 22(100):423-9. PubMed ID: 22799143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
    Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
    Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy].
    Sárosi A
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):179-87. PubMed ID: 17211053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
    Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
    J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variants of changes in the psychopathological phenomenology of the long-term remission in stable patients with attack-like progressive form of schizophrenia: a longitudinal study].
    Morozova MA; Burminskiy DS; Rupchev GE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):22-29. PubMed ID: 26356511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of baseline antipsychotic status on the 12-month outcome in initially stabilized patients with schizophrenia.
    Fountoulakis KN; Panagiotidis P; Nimatoudis I
    Hum Psychopharmacol; 2019 Sep; 34(5):e2712. PubMed ID: 31486169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
    Agid O; Foussias G; Remington G
    Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.